In Segment A, individuals will obtain different doses and schedules of oral ABBV-744 tablet to discover safe dosing routine. More individuals are going to be enrolled on the determined monotherapy dosign routine. In Section B, members will acquire oral ruxolitinib and ABBV-744 will probably be supplied as "add-on" therapy. In https://abbv-744inacutemyeloidleu12457.dm-blog.com/32139428/the-best-side-of-abbv-744-clinical-trial-phase-1-results